Home Newsletters Immunology of Infectious Disease News Masitinib Is a Broad Coronavirus 3CL Inhibitor That Blocks Replication of SARS-CoV-2

Masitinib Is a Broad Coronavirus 3CL Inhibitor That Blocks Replication of SARS-CoV-2

0
Investigators screened a library of 1900 clinically safe drugs against OC43, a human beta coronavirus that causes the common cold, and evaluated the top hits against SARS-CoV-2.
[Science]
6445218 {6445218:DGZVYH55} apa 50 1 166051 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version